Quarterly Result30 May 2026, 08:51 pm
Samrat Pharmachem Adopts FY26 Audited Results
AI Summary
Samrat Pharmachem Ltd. announced the adoption of audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the results at a meeting held on May 30, 2026. Revenue from operations stood at ₹28,972.12 lakhs for the year ended March 31, 2026, compared to ₹28,586.05 lakhs in the previous year. The company reported a loss for the year at ₹331.20 lakhs, against a profit of ₹711.22 lakhs last year. The 34th AGM is scheduled for September 23, 2026.
Key Highlights
- Audited financial results for FY26 were adopted by the Board on May 30, 2026.
- Revenue from operations for FY26 reached ₹28,972.12 lakhs.
- The company reported a net loss of ₹331.20 lakhs for FY26.
- The 34th Annual General Meeting is set for September 23, 2026.
- Register of Members will be closed from September 17 to September 23, 2026.
Price Impact
More from SAMRATPH